SMTL ID : 7k6o.1

Crystal structure of PI3Kalpha inhibitor 10-5429

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.74 Å

Oligo State

monomer

Ligands

1 x VY1: (3S)-3-[4-(2-aminopyrimidin-5-yl)-2-(morpholin-4-yl)-5,6-dihydro-7H-pyrrolo[2,3-d]pyrimidin-7-yl]-N-methylpyrrolidine-1-sulfonamide(Non-covalent)

VY1.1: 22 residues within 4Å: Chain A: R.668, M.670, S.672, W.678, I.698, K.700, D.703, L.705, D.708, Y.734, I.746, E.747, V.748, V.749, S.752, H.753, T.754, Q.757, M.820, F.828, I.830, D.831 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:I.746, A:I.830 Hydrogen bonds: A:R.668, A:R.668, A:K.700, A:V.749, A:Q.757, A:Q.757, A:D.831 Salt bridges: A:D.703, A:D.708, A:D.831

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Cheng, H. et al., Structure-Based Drug Design and Synthesis of PI3K alpha-Selective Inhibitor (PF-06843195). J.Med.Chem. (2021)

Release Date

2021-01-06

Peptides

Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform

Related Entries With Identical Sequence